News from ptc therapeutics, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-SMALL:CTIC)

Dec 21, 2010, 08:00 ET
PTC Therapeutics logo. (PRNewsFoto/PTC Therapeutics, Inc.)

PTC Therapeutics Completes Enrollment of Phase 3 Trial of Ataluren in Patients with Cystic Fibrosis

PTC Therapeutics, Inc. announced today that it has completed enrollment of a Phase 3 clinical trial of ataluren, an investigational new drug, in...

Dec 01, 2010, 08:00 ET

Observational Data From One-Year Follow-up Study Validate Six-Minute Walk Distance as an Outcome Measure in Duchenne and Becker Muscular Dystrophy

Data published in the December issue of the medical journal Muscle and Nerve confirm the utility of six-minute walk distance (6MWD) as a...

Nov 15, 2010, 08:00 ET

PTC Publishes Results from Phase 2 Study of Ataluren in Children with Cystic Fibrosis

PTC Therapeutics, Inc. today announced the publication of data from a Phase 2a clinical trial of ataluren in children with nonsense mutation cystic...

Oct 26, 2010, 08:00 ET
PTC Therapeutics logo. (PRNewsFoto/PTC Therapeutics, Inc.)

PTC Therapeutics Initiates Phase 2 Clinical Trial of Ataluren in Patients With Methylmalonic Acidemia

PTC Therapeutics, Inc. today announced that it is expanding the development of ataluren, an investigational new drug, with the initiation of a...

Oct 15, 2010, 08:00 ET
PTC Therapeutics logo. (PRNewsFoto/PTC Therapeutics, Inc.)

Pivotal Data Presented at the World Muscle Society Congress Suggest Ataluren Slows the Loss of Walking Ability in Patients with Nonsense Mutation Duchenne/Becker Muscular Dystrophy

PTC Therapeutics, Inc. today announced that final analyses of Phase 2b efficacy data suggest the investigational new drug ataluren slowed the loss...

Sep 21, 2010, 08:00 ET
PTC Therapeutics logo. (PRNewsFoto/PTC Therapeutics, Inc.)

PTC Therapeutics Awarded $1.6 Million FDA Orphan Drug Grant to Support an Ongoing Phase 3 Study in Cystic Fibrosis

PTC Therapeutics, Inc. (PTC) today announced a grant award of approximately $1.6 million from the U.S. Food and Drug Administration (FDA) Office...

Jun 07, 2010, 08:00 ET

PTC Therapeutics Awarded $5.4 Million Grant From The Wellcome Trust

PTC Therapeutics, Inc. (PTC) today announced the receipt of a $5.4 million Seeding Drug Discovery (SDD) Award from The Wellcome Trust to support...

Jan 19, 2010, 08:00 ET
A F PTC THERAPEUTICS, INC. PTC THERAPEUTICS, INC.

PTC Therapeutics logo. (PRNewsFoto/PTC Therapeutics, Inc.)[MF]
 SOUTH PLAINFIELD, N.J. UNITED STATES
 03/31/2006

PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy

PTC Therapeutics, Inc. (PTC) today announced the initiation of an additional clinical trial of ataluren (PTC124®) in boys and young men with...

Dec 22, 2009, 08:00 ET
A F PTC THERAPEUTICS, INC. PTC THERAPEUTICS, INC.

PTC Therapeutics logo. (PRNewsFoto/PTC Therapeutics, Inc.)[MF]
 SOUTH PLAINFIELD, N.J. UNITED STATES
 03/31/2006

PTC Therapeutics Closes $50 Million Financing

PTC Therapeutics, Inc. (PTC) today announced the completion of a $50 million financing. The round was led by The Column Group - a new investor...

Dec 08, 2009, 08:00 ET
A F PTC THERAPEUTICS, INC. PTC THERAPEUTICS, INC.

PTC Therapeutics logo. (PRNewsFoto/PTC Therapeutics, Inc.)[MF]
 SOUTH PLAINFIELD, N.J. UNITED STATES
 03/31/2006

Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy

Data published online in the medical journal Muscle and Nerve support the use of the six-minute walk test (6MWT) as an outcome measure in PTC...

Dec 02, 2009, 07:00 ET
A F PTC THERAPEUTICS, INC. PTC THERAPEUTICS, INC.

PTC Therapeutics logo. (PRNewsFoto/PTC Therapeutics, Inc.)[MF]
 SOUTH PLAINFIELD, N.J. UNITED STATES
 03/31/2006

PTC Therapeutics Receives $1 Million Challenge Grant Award from the National Institutes of Health

PTC Therapeutics, Inc. (PTC) today announced the receipt of a $1 million Challenge Grant award from the National Heart, Lung, and Blood...

Oct 26, 2009, 08:00 ET
A F PTC THERAPEUTICS, INC. PTC THERAPEUTICS, INC.

PTC Therapeutics logo. (PRNewsFoto/PTC Therapeutics, Inc.)[MF]
 SOUTH PLAINFIELD, N.J. UNITED STATES
 03/31/2006

PTC Therapeutics Initiates Phase 2 Clinical Trial of ataluren (PTC124(R)) in Patients with Hemophilia

PTC Therapeutics, Inc. (PTC) today announced it is expanding the development of ataluren, an investigational new drug, to a third indication...

Sep 10, 2009, 08:00 ET
A F PTC THERAPEUTICS, INC. PTC THERAPEUTICS, INC.

PTC Therapeutics logo. (PRNewsFoto/PTC Therapeutics, Inc.)[MF]
 SOUTH PLAINFIELD, N.J. UNITED STATES
 03/31/2006

PTC Therapeutics Initiates Registration-Directed Phase 3 Trial of Ataluren in Cystic Fibrosis

PTC Therapeutics, Inc. (PTC) today announced the initiation of a Phase 3 trial of ataluren (formerly PTC124(R)), an investigational protein...

Sep 02, 2009, 08:00 ET
A F PTC THERAPEUTICS, INC. PTC THERAPEUTICS, INC.

PTC Therapeutics logo. (PRNewsFoto/PTC Therapeutics, Inc.)[MF]
 SOUTH PLAINFIELD, N.J. UNITED STATES
 03/31/2006

PTC Therapeutics Announces Celgene Exercised Option to Drug Discovery Collaboration

PTC Therapeutics, Inc. (PTC) today announced that Celgene Corporation has exercised its option to collaborate on advancing drug discovery efforts...

Sep 02, 2009, 08:00 ET
A F PTC THERAPEUTICS, INC. PTC THERAPEUTICS, INC.

PTC Therapeutics logo. (PRNewsFoto/PTC Therapeutics, Inc.)[MF]
 SOUTH PLAINFIELD, N.J. UNITED STATES
 03/31/2006

PTC Therapeutics Announces Drug Discovery Collaboration With Roche

PTC Therapeutics, Inc. (PTC) today announced an exclusive research collaboration and licensing agreement with Roche for the development of...

Aug 10, 2009, 08:00 ET
A F PTC THERAPEUTICS, INC. PTC THERAPEUTICS, INC.

PTC Therapeutics logo. (PRNewsFoto/PTC Therapeutics, Inc.)[MF]
 SOUTH PLAINFIELD, N.J. UNITED STATES
 03/31/2006

PTC Therapeutics Announces Achievement of Major Milestone in Schering-Plough Hepatitis C Collaboration

PTC Therapeutics, Inc. (PTC) today announced that it has reached a major research milestone in its collaboration with Schering-Plough...

Jul 27, 2009, 08:00 ET
A F PTC THERAPEUTICS, INC. PTC THERAPEUTICS, INC.

PTC Therapeutics logo. (PRNewsFoto/PTC Therapeutics, Inc.)[MF]
 SOUTH PLAINFIELD, N.J. UNITED STATES
 03/31/2006

PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2

PTC Therapeutics, Inc. (PTC) today announced the initiation of a Phase 2 clinical trial of PTC299 in adult patients with neurofibromatosis type...

Jun 15, 2009, 08:00 ET
A F PTC THERAPEUTICS, INC. PTC THERAPEUTICS, INC.

PTC Therapeutics logo. (PRNewsFoto/PTC Therapeutics, Inc.)[MF]
 SOUTH PLAINFIELD, N.J. UNITED STATES
 03/31/2006

PTC Therapeutics Receives $2.6 Million in Government Grants

- Funding supports continued focus on rare disorders - PTC Therapeutics, Inc. (PTC) today announced the receipt of two government grants to...

Jun 01, 2009, 08:00 ET
A F PTC THERAPEUTICS, INC. PTC THERAPEUTICS, INC.

PTC Therapeutics logo. (PRNewsFoto/PTC Therapeutics, Inc.)[MF]
 SOUTH PLAINFIELD, N.J. UNITED STATES
 03/31/2006

PTC Therapeutics Appoints Clare Kennedy as Vice President of Commercial Operations

PTC Therapeutics, Inc. (PTC) today announced that Clare Kennedy has been appointed as Vice President of Commercial Operations. In this role, she...

May 12, 2009, 08:00 ET
A F PTC THERAPEUTICS, INC. PTC THERAPEUTICS, INC.

PTC Therapeutics logo. (PRNewsFoto/PTC Therapeutics, Inc.)[MF]
 SOUTH PLAINFIELD, N.J. UNITED STATES
 03/31/2006

PTC Therapeutics and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration

Project will advance novel platform for treatment of Spinal Muscular Atrophy PTC Therapeutics, Inc. (PTC) and the Spinal Muscular Atrophy (SMA)...